Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.
- 1 July 2003
- journal article
- research article
- Vol. 30 (7), 1426-35